Sage Journals: Discover world-class research

Abstract

Aims

Extracellular matrix remodelling may influence atherosclerotic progression and plaque stability. We hypothesized that evaluation of extracellular matrix markers, with potentially different roles during atherogenesis, could provide information on underlying mechanisms and risk of myocardial infarction (MI) in apparently healthy individuals.

Methods

We conducted a case–control study nested within the population-based HUNT2 cohort in Norway. A total of 58,761 men and women, free of known cardiovascular disease, were followed for a first MI. During 11.3 years of follow-up, 1587 incident MIs were registered, and these cases were compared with 3959 age- and sex-matched controls. Circulating levels of the ECM proteins CD147 (ECM metalloproteinase inducer; EMMPRIN), cartilage oligomeric matrix protein (COMP: thrombospondin-5) and YKL-40 (chitinase-3-like-1) were measured by enzyme immunoassays.

Results

We found an inverse association between COMP (quartile (Q) 4 vs. Q1: hazard ratio 0.81 (95% confidence interval: 0.67–0.98)) and YKL-40 (Q4 vs. Q1: hazard ratio 0.77 (0.62–0.95)) with incidence of MI after full multivariable adjustment. Serum CD147 was not associated with MI risk in adjusted analysis.

Conclusion

High levels of COMP and YKL-40 were associated with lower risk of incident MI, suggesting a potential beneficial role in promoting plaque stability in individuals without incident cardiovascular disease.

Keywords

Extracellular matrix myocardial infarction YKL-40 case–control

Get full access to this article

View all access options for this article.

References

O’Gara

Kushner

Ascheim

. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: e78–e140.

Libby

. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013; 368: 2004–2013.

Shah

. Biomarkers of plaque instability. Curr Cardiol Rep 2014; 16: 547–547.

Ketelhuth

Back

. The role of matrix metalloproteinases in atherothrombosis. Curr Atheroscler Rep 2011; 13: 162–169.

Mathiasen

Henningsen

Harutyunyan

. YKL-40: A new biomarker in cardiovascular disease? Biomark Med 2010; 4: 591–600.

Bond

Hultgardh-Nilsson

Knutsson

. Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions. Atherosclerosis 2014; 236: 366–372.

Pennings

Kritharides

. CD147 in cardiovascular disease and thrombosis. Seminars in thrombosis and hemostasis 2014; 40: 747–755.

Boot

van Achterberg

van Aken

. Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999; 19: 687–694.

Rathcke

Vestergaard

. YKL-40 – an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009; 8: 61–61.

10.

Rehli

Niller

Ammon

. Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem 2003; 278: 44058–44067.

11.

Malinda

Ponce

Kleinman

. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999; 250: 168–173.

12.

Shackelton

Mann

Millis

. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 1995; 270: 13076–13083.

13.

Schmidt

Bultmann

Ungerer

. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: Implications in acute myocardial infarction. Circulation 2006; 113: 834–841.

14.

Michelsen

Rathcke

Skjelland

. Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 2010; 211: 589–595.

15.

Riessen

Fenchel

Chen

. Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001; 21: 47–54.

16.

Kastrup

Johansen

Winkel

. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J 2009; 30: 1066–1072.

17.

Yong

Pennings

Wong

. Intracoronary upregulation of platelet extracellular matrix metalloproteinase inducer (CD147) in coronary disease. Int J Cardiol 2013; 166: 716–721.

18.

Kjaergaard

Bojesen

Johansen

. Elevated plasma YKL-40 levels and ischemic stroke in the general population. Ann Neurol 2010; 68: 672–680.

19.

Rathcke

Thomsen

Linneberg

. Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke. PloS One 2012; 7: e43498–e43498.

20.

Ridker

Chasman

Rose

. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events. J Am Heart Assoc 2014; 3: e000897–e000897.

21.

Kjaergaard

Johansen

Bojesen

. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population. Stroke 2015; 46: 329–335.

22.

Laugsand

Vatten

Platou

. Insomnia and the risk of acute myocardial infarction: A population study. Circulation 2011; 124: 2073–2081.

23.

Alpert

Thygesen

Antman

. Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–969.

24.

Rothman

Greenland

Lash

. Modern epidemiology, 3rd edn. Philadelphia, PA: Lippincott Williams & Willkins, 2008.

25.

Breslow

Lubin

Marek

. Multiplicative models in cohort analysis. J Am Stat Assoc 1983; 78: 1–12.

26.

Dahabreh

Kent

. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 2011; 305: 822–823.

27.

Iwata

Kuwajima

Sukeno

. YKL-40 secreted from adipose tissue inhibits degradation of type I collagen. Biochem Biophys Res Commun 2009; 388: 511–516.

28.

Ling

Recklies

. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J 2004; 380: 651–659.

29.

Gratchev

Schmuttermaier

Mamidi

. Expression of osteoarthritis marker YKL-39 is stimulated by transforming growth factor beta (TGF-beta) and IL-4 in differentiating macrophages. Biomark Insights 2008; 3: 39–44.

30.

Halasz

Kassner

Morgelin

. COMP acts as a catalyst in collagen fibrillogenesis. J Biol Chem 2007; 282: 31166–31173.

31.

Sturhan

Ungern-Sternberg

Langer

. Regulation of EMMPRIN (CD147) on monocyte subsets in patients with symptomatic coronary artery disease. Thromb Res 2015; 135: 1160–1164.

32.

Pennells

Kaptoge

White

. Emerging Risk Factors Collaboration. Assessing risk prediction models using individual participant data from multiple studies. Am J Epidemiol 2014; 179: 621–632.

33.

Arain

Gullestad

Nymo

. Low YKL-40 in chronic heart failure may predict beneficial effects of statins: Analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA). Biomarkers 2016, pp. 1–7.

34.

Forsdahl

Singh

Solberg

. Risk factors for abdominal aortic aneurysms: A 7-year prospective study: The Tromso Study, 1994–2001. Circulation 2009; 119: 2202–2208.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.55 MB

Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway

Abstract

Aims

Methods

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material